Cargando…
Toll-like Receptor 2 as a Marker Molecule of Advanced Ovarian Cancer
Ovarian cancer is a global problem that affects women of all ages. Due to the lack of effective screening tests and the usually asymptomatic course of the disease in the early stages, the diagnosis is too late, with the result that less than half of the patients diagnosed with ovarian cancer (OC) su...
Autores principales: | Sobstyl, Małgorzata, Niedźwiedzka-Rystwej, Paulina, Hrynkiewicz, Rafał, Bębnowska, Dominika, Korona-Głowniak, Izabela, Pasiarski, Marcin, Sosnowska-Pasiarska, Barbara, Smok-Kalwat, Jolanta, Góźdź, Stanisław, Sobstyl, Anna, Polkowski, Wojciech, Roliński, Jacek, Grywalska, Ewelina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394498/ https://www.ncbi.nlm.nih.gov/pubmed/34439871 http://dx.doi.org/10.3390/biom11081205 |
Ejemplares similares
-
CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer
por: Bębnowska, Dominika, et al.
Publicado: (2020) -
Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review
por: Grywalska, Ewelina, et al.
Publicado: (2020) -
Immunological Prognostic Factors in Multiple Myeloma
por: Bębnowska, Dominika, et al.
Publicado: (2021) -
Toll-Like Receptor 2 Expression as a New Hallmark of Advanced Endometriosis
por: Sobstyl, Małgorzata, et al.
Publicado: (2020) -
Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
por: Grywalska, Ewelina, et al.
Publicado: (2020)